Business Trends

May 01, 2015
BioPharm International
The Australian pharmaceutical market offers opportunities for manufacturers despite challenges.
Apr 01, 2015
BioPharm International
Hope abounds for local drug discovery companies despite challenges at home.
Mar 06, 2015
By BioPharm International Editors
Mallinckrodt Pharmaceuticals has bought Ikaria, a privately-held critical care company, for $2.3 billion.
Feb 06, 2015
BioPharm International
Changes in the country’s political landscape may affect the pharmaceutical industry market in the future.
Feb 01, 2015
BioPharm International
Investors are lining up for the biosimilars market as patents reach expiration and regulatory pathways are defined.
Jan 01, 2015
BioPharm International
Manufacturers are under pressure to develop pipelines, promote quality, and justify pricing.
Dec 30, 2014
BioPharm International
Although competing therapies will continue to be released in the immuno-oncology space, efficacy profiles, combination regimens, and administration setting may influence a drug’s preferred status more than price.
Dec 22, 2014
BioPharm International
Pharmacy benefit manager Express Scripts offers Viekira Pak at a discount and excludes the drug’s higher-priced competitors from its formulary.
Dec 09, 2014
BioPharm International
By BioPharm International Editors
On December 8, Pfizer announced that it will establish a research program in gene therapy, and collaborate with Spark Therapeutics in Philadelphia, to develop potential gene therapy treatments for hemophilia.
Dec 03, 2014
BioPharm International
By BioPharm International Editors
Enhanced R&D efforts and the growing manufacture of finished-dosage drugs in India will shape the country's future success, according to a new report from CPhI.
native1_300x100
lorem ipsum